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1Fortgeschrittene Anwendungen der 
in vivo MR Spektroskopie
6. Doktorandentraining der




• 1H Spektroskopie im Rattenhirn bei 9.4T -
Quantifizierung in der Frequenzdomäne (LCModel) 
• Diffusionsgewichtete 1H Spektroskopie von Wasser
und Metaboliten bei grossen b-Werten -
technische Aspekte und Anwendungen










9.4 T / 31 cm Towards an In Vivo Neurochemical Profile: 
Quantification of 18 Metabolites 
in 1H NMR Spectra of Rat Brain at TE=2 ms
• improved sensitivity for in vivo 1H MRS by the increased
spectral resolution at high magnetic fields
® detection of PCr, phosphoethanolamine (PE)
• quantitation of  hitherto poorly resolved metabolites
e.g. PCr, GABA, Gln, Tau, Glc, GSH, Ala, resting Lac
• determination of the macromolecule baseline in ultra-short echo 
time spectra based on T1 differences
Methods
• male Sprague-Dawley rats (n > 20) 
• 9.4 Tesla / 31 cm  Magnex / Varian INOVA system
quadrature 1H surface coil
• STEAM (64 mL voxel) with VAPOR (7 optimized  water 
suppression pulses) and OVS     (Tkac et al., 1999)
• TE = 2 ms,  TM = 20 ms, TR = 6 sec
• FASTMAP shimming (1st and 2nd order)   












1H NMR spectroscopy in rat brain at 9.4 T








metabolite nulling at tIR = 950 ms
removal of residual
Cr/PCr at 3.92 ppm 
by HLSVD
ppm
TE = 2 ms





















TE = 2 ms
nt = 512
residual
Lac - 2.8 mM (3%)
PCr Cr
Ala - 0.55 mM (13%)
NAA - 8.9 mM (1%)
NAA
Cr - 4.7 mM (2%) 
PCr - 3.9 mM (3%)
Cr+PCr - 8.5 mM (1%)
Tau - 6.0 mM (2%)





Glu - 8.3 mM (2%)
myo-Ins - 4.4 mM (2%)
scyllo-Ins




3GABA - 0.77 mM (12%)
GSH - 0.78 mM (9%)
phosphoethanolamine - 1.7 mM (6%)
ppm
PCr Cr Ins PCr CrInsIns PE InsTau TauPE




• Cramér-Rao lower bounds
CR < 4% NAA, Cr, PCr, Tau, myo-Ins, Glu, Gln, Lac
CR < 13% GPC+PC, PE, Glc, GSH, GABA, NAAG, Ala
CR < 22% scyllo-Ins, Asp
• NAA / (Cr+PCr) ratio =   1.05
• choline concentration very low 0.5 mM (6%)




















Reproducibility of 3-min spectra (64 mL)
Gln - 7.3 mM (2%)
3-fold elevated





• neurochemical profile of 18 metabolites in rat brain, 
most with Cramér-Rao lower bounds <  10%
• concentrations of  phosphocreatine, phosphoethanolamine, 
g-aminobutyric acid, glutathione, and alanine from
in vivo 1H NMR spectra without any editing
• maximum of spectral information possible with ultra-short
echo times due to high sensitivity and excellent shimming
4• Why do we need experiments at large diffusion weighting ?
• What about modeling a multi-exponential decay ?
compartments vs. components
• Diffusion-weighted 1H spectroscopy of cerebral metabolites:
intracellular and extracellular contribution
• Diffusion-weighted 13C spectroscopy:
metabolically active tracer (glucose ® lactate)
Diffusion-Weighted Spectroscopy of Water and 
Cerebral Metabolites at Very Large b Values –
What Multiple Components Tell us


















TR = 3 s
perfused glial cells
Monitoring of intracellular water at large b
cardiac
arrest
40 s 60 s
b value
13.3 ms/mm2


















time  /  s
rat brain











b value  /  ms mm-2
global ischemic rat
healthy rat
Multiexponential decay in rat brain tissue
• metabolites in brain are mostly intracellular « glucose
and lactate have substantial extracellular contribution
• assumption that glucose in brain is equally distributed
in the extra- and intracellular space (in vitro studies) 
• potential concentration gradients at the extra- / intra-
cellular interface in vivo ?
• diffusion-weighted 1H NMR spectroscopy has provided
methods to separate intracellular contributions
® gain indirect knowledge of extracellular fraction
Diffusion-weighted 1H spectroscopy 
of cerebral metabolites
b = 0




9.4 T/ 31 cm system
(Gx,y,z = 300 mT/m)
6 x 2.8 x 6   mm3 voxel
diffusion time   tD = 122 ms
5ppm




ADC (NAA) = 0.11 ® 0.13
Effect of single trace phase correction
ppm









• highly resolved spectral features
• full pattern used for quantification
Quantification of glucose
increasing strength of diffusion weighting:   b value = 5 ms/mm2
macromolecules
Dapp (NAA) = 0.11 mm2 /ms
diffusion time 122 ms
® displacement  r app ~ 5 mm
NAA
Diffusion weighting





















( n = 12 )




Signals of intracellular metabolites are NOT discernible









Dapp (NAA) = 0.11 mm2 /ms
Dapp (Glc) = 0.14
Dapp (Lac) = 0.18




* p < 0.001
t-test
Apparent diffusion coefficient of glucose and lactate
6b = 0









b = 0 - 50 ms/mm2
1H NMR signals in vivo at very large diffusion weighting





NAA: p2 = 49±1% 
D2 = 0.024 mm2 /ms
Glc:   p2 = 40±2%
D2 = 0.026
Lac
( n = 8, 
stdev )






Glc, Lac: decreased fraction p2 at large b values
• bi-exponential model - two intracellular components p1, p2
® separable component p2 at large b values, 
e.g., NAA as internal standard:   p1 : p2 ~  1 : 1
• glucose is known to have extracellular contribution
® calculation from p2 and ratio p1 : p2 ,
e.g., Glc:   p2 = 40% = p1 ® pextra = 1 – p1 – p2
• extracellular fraction pextra (Glc) = 19±5% is consistent
with equally distributed glucose in brain
Estimation of the extracellular fraction

































Volume fraction p2 vs. diffusion coefficient D2
Localized in vivo 1H NMR detection of neurotransmitter
labeling during infusion of [1-13C] D-glucose
• Indirect 1H detection of 13C label, e.g. POCE, HSQC 
® more sensitive, but spectral resolution reduced
– is detection of 13C enrichment in resonances like
Gln, GABA, Lac, and Ala possible ?
– resolve Gln from Glu resonances?
• broadband 13C decoupling in vivo at 9.4 Tesla 
• simultaneous 1H and 13C information: 
® concentrations and 13C fractional enrichment
• 1H quadrature / 13C linear triple-turn surface coil
• male SD rats  ® [1-13C] glucose infusion (16 mg/min)
• localization based on STEAM with VAPOR water 
suppression and OVS     (Tkac et al., MRM 41, 649, 1999)
• localization 7 x 2.8 x 7   mm3  voxel (137 mL)





























Soff Son Soff - Son
ACED - Editing process














TE = 7.9 ms
nt = 1280
ACED subspectrum - Soff
( x 20 )














TE = 7.9 ms
summed over 3h
4 kHz with 
tanh/tan
12 kHz  decoupling with  hs8 (R=20)











decoupler frequency @ 35 ppm




• decoupling applied during 400 ms acquisition
• adiabatic AFP pulses on carbon channel:
[ tanh / tan, R = 54 ]  - 1.5 ms
® 4 kHz decoupling width (40 ppm)
[ hs8, R = 20 ]  - 1.8 ms
® 12 kHz decoupling width (120 ppm)
• five-step phase cycle combined with MLEV-4
• gB2 ~ 1 kHz,  peak decoupler power below 2 W





with/ without hs8 decoupling
doffset(13C) @ 35 ppm
BW = 12 kHz / 120 ppm
TE = 6 ms / JCH(Glc)
30 min interleaved acquisition
225 scans each
Ala, Lac doublet detectable
despite low concentration


















ACED detection of 13C label in glutamate and glutamine C3
























• ACED for editing with localized 1H{13C} detection
® adiabatic inversion, adiabatic broadband decoupling
• very short TE possible for editing (T2 effects, JHH)
• simultaneous 13C label detection and
total 1H {12C+13C} metabolite concentration
• detection of separate Glu - Gln in positions C4 
® deconvolution of C3 peaks possible
Summary





































13C labeling and fractional enrichment
9Conclusions
• high resolution and sensitivity at high magnetic fields
® full advantage of 1H methods for localization
• in vivo detection of 13C labeling in multiple positions:
® energy metabolism and neurotransmission
• 13C label in glutamine, lactate, GABA, and aspartate
• simultaneous monitoring of glucose, lactate, and phosphocreatine
• diffusion-weighted 1H NMR spectroscopy difficult to perform 
in vivo due to low concentration of cerebral metabolites
• diffusion-weighted 13C NMR spectroscopy only done in vitro
with very long acquisitions times          [ Malveau C et al. JMR 1998]
• indirect 1H detection of 13C label is more sensitive -
many technical issues (e.g. hardware, carbon decoupling)
• 13C labeling provides more specific answers and eliminates
unwanted signals   (e.g., lipid overlap with lactate signal)
Diffusion-weighted spectroscopy 














Diffusion-weighted  ACED sequence
b = 0 0.4 1 2 
ms/mm2









Editing of [3-13C] lactate - phantom data
b = 0 0.4 1 2 
ms/mm2
b = 0 0.4 1 2 
ms/mm2
{ 1H-[12C+13C] } { 1H-[13C] }
total lactate
(1.32 ppm)
signal of protons 
bound to [3-13C] lactate
60%
enriched
Diffusion-weighted ACED – with decoupling
volume sizes 120 - 150 ml
( 6 x 4 x 6 mm3 )
tumor model: male Fisher rats, measured 12-14 days 
after inoculation with 9L glioma (right hemisphere)
continuous infusion of 70%-enriched [1-13C] glucose:
[3-13C] lactate turnover into steady state after one hour
Diffusion-weighted spectroscopy 
of 13C-labeled lactate in rat glioma in vivo
10














1H spectrum of 9L glioma
eight  b values




Diffusion-weighted series of in vivo lactate and alanine





tD = 122 ms
TE = 23 ms
TR = 4 s
In vivo DW [3-13C] lactate and [3-13C] alanine Features of diffusion-weighted 13C spectroscopy
• specific information by 13C labeling depending on metabolism
normal: Glc ® Glu/Gln, tumor: Glc ® Lac/Ala
• selectivity and localization in metabolically-active tissue
• detection of lactate without lipid contamination
• simultaneous DW 1H spectral information:  Cho, Cr, Glu, Gly, PE
• dynamic information ® labeling time course from turnover
® changes of metabolite ADC reflect location
e.g., CSF, extracellular, intracellular compartment
• lactate in 9L glioma is metabolic product of glucolysis




9L tumor in rat 
(4.7T)
J.C. Lin et al., 2000
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